Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings Market Cap : 0.3655M for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 0.3655M |
| November 16, 2026 | 0.3959M |
| November 13, 2026 | 0.3844M |
| November 12, 2026 | 0.3922M |
| November 11, 2026 | 0.3972M |
| November 10, 2026 | 0.5253M |
| November 09, 2026 | 0.5296M |
| November 06, 2026 | 0.5082M |
| November 05, 2026 | 0.4954M |
| November 04, 2026 | 0.5082M |
| November 03, 2026 | 0.4869M |
| November 02, 2026 | 0.551M |
| October 30, 2026 | 0.6449M |
| October 29, 2026 | 0.8115M |
| October 28, 2026 | 0.8158M |
| October 27, 2026 | 0.7816M |
| October 26, 2026 | 0.709M |
| October 23, 2026 | 0.7263M |
| October 22, 2026 | 0.7303M |
| October 21, 2026 | 0.6492M |
| October 20, 2026 | 0.7261M |
| October 19, 2026 | 0.709M |
| October 16, 2026 | 1.012M |
| October 15, 2026 | 1.034M |
| October 14, 2026 | 1.059M |
| Date | Value |
|---|---|
| October 13, 2026 | 1.068M |
| October 12, 2026 | 1.170M |
| October 09, 2026 | 1.226M |
| October 08, 2026 | 1.209M |
| October 07, 2026 | 1.183M |
| October 06, 2026 | 1.286M |
| October 05, 2026 | 1.204M |
| October 02, 2026 | 1.128M |
| October 01, 2026 | 1.034M |
| September 30, 2026 | 1.089M |
| September 29, 2026 | 1.23M |
| September 28, 2026 | 1.081M |
| September 25, 2026 | 1.025M |
| September 24, 2026 | 1.140M |
| September 23, 2026 | 1.121M |
| September 22, 2026 | 17.01M |
| September 21, 2026 | 16.71M |
| September 18, 2026 | 15.41M |
| September 17, 2026 | 15.66M |
| September 16, 2026 | 15.86M |
| September 15, 2026 | 15.37M |
| September 14, 2026 | 18.45M |
| September 11, 2026 | 17.78M |
| September 10, 2026 | 19.70M |
| September 09, 2026 | 17.65M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.082B |
| Alnylam Pharmaceuticals, Inc. | 20.01B |
| Anika Therapeutics, Inc. | 182.43M |
| Savara, Inc. | 973.21M |
| Arrowhead Pharmaceuticals, Inc. | 6.092B |
Market Cap Related Metrics
| Price to Book Value | 0.3216 |
| Price | 0.8557 |
| Earnings Yield | -2.50K% |